Last updated: July 05, 2026

Application No. 18/609,806

COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROLOGICAL DISORDERS

Non-Final OA

Filed

Mar 19, 2024

Priority

Aug 28, 2014 — provisional 62/042,979 +7 more

Examiner

RAO, SAVITHA M

Art Unit

1691

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

THE GENERAL HOSPITAL Corporation

OA Round

1 (Non-Final)

This examiner grants 61% of cases after interview

— +29.7% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 1173 resolved cases, 2023–2026

Examiner Intelligence

RAO, SAVITHA M View full profile →

Grants 61% of resolved cases

Career Allowance Rate

712 granted / 1173 resolved

+0.7% vs TC avg

Strong +30% interview lift

Without

With

+29.7%

Interview Lift

resolved cases with interview

Typical timeline

2y 8m

Avg Prosecution

42 currently pending

Career history

1204

Total Applications

across all art units

Statute-Specific Performance

§101

0.7%

-39.3% vs TC avg

§103

55.4%

+15.4% vs TC avg

§102

7.8%

-32.2% vs TC avg

§112

8.4%

-31.6% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1173 resolved cases

Prosecution Timeline

Mar 19, 2024

Application Filed

Apr 23, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/282,365

Patent 12667540

ROLLED ORAL THIN FILMS HAVING A HIGH LEVEL OF ACTIVE-INGREDIENT LOADING

2y 9m to grant Granted Jun 30, 2026

18/254,753

Patent 12653835

PHOSPHONATES AS INHIBITORS OF ENPP1 AND CDNP

3y 0m to grant Granted Jun 16, 2026

18/255,229

Patent 12653798

FIXED COMBINATION MEDICINE FOR THE CONTROL AND MANAGEMENT OF NEUROPATHIC PAIN

3y 0m to grant Granted Jun 16, 2026

17/796,076

Patent 12636275

PHARMACEUTICAL USE OF KETOAMIDE-BASED COMPOUND

3y 9m to grant Granted May 26, 2026

17/914,529

Patent 12636268

CXCL8 INHIBITORS FOR USE IN THE TREATMENT OF COVID-19

3y 8m to grant Granted May 26, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

61%

Grant Probability

90%

With Interview (+29.7%)

2y 8m (~4m remaining)

Median Time to Grant

Low

PTA Risk

Based on 1173 resolved cases by this examiner. Grant probability derived from career allowance rate.